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Precise contact between epithelial cells and their underlying basement membrane is 
critical to the maintenance of tissue architecture and function. To understand the role that 
the laminin receptor dystroglycan (DG) plays in these processes, we assayed cell 
responses to laminin-111 following conditional ablation of DG expression in cultured 
mammary epithelial cells (MECs).  Strikingly, DG loss disrupted laminin-111-induced 
polarity and β-casein production, and abolished laminin assembly at the step of laminin 
binding to the cell surface.  DG re-expression restored these deficiencies.  Investigations 
of mechanism revealed that DG cytoplasmic sequences were not necessary for laminin 
assembly and signaling, and only when the entire mucin domain of extracellular DG was 
deleted did laminin assembly not occur.   These results demonstrate that DG is essential 
as a laminin-111 co-receptor in MECs that functions by mediating laminin anchoring to 
the cell surface, a process that allows laminin polymerization, tissue polarity, and β-
casein induction.  The observed loss of laminin-111 assembly and signaling in DG-/- 
MECs provides insights into the signaling changes occurring in breast carcinomas and 
other cancers, where DG’s laminin-binding function is frequently defective. 
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Introduction 
Laminins are important structural and signaling components of basement membranes 
(BMs), serving as critical modulators of BM assembly, cellular architecture, and tissue 
morphogenesis and function (Miner and Yurchenco, 2004).  Interaction of laminins with 
epithelial cells influences such cellular responses as adhesion, polarity, and survival (Li et 
al., 2003).  Genetic defects in laminin subunits result in muscular dystrophies and skin 
blistering (Miner and Yurchenco, 2004) and disregulated cell-laminin interactions have 
been implicated in the progression of cancers (Patarroyo et al., 2002).  We are using the 
mammary gland as a model system for understanding cellular interactions with laminins 
that regulate signals for epithelial architecture and function.  Laminin-111 [(previously 
named laminin-1(Aumailley et al., 2005)] is a key player in these processes in mammary 
epithelial cells (MECs), inducing polarization (Gudjonsson et al., 2002; Slade et al., 
1999) and β-casein production (Streuli et al., 1995).  The identities of the multiple 
laminin receptors which elicit these effects are not completely understood, nor are the 
cooperative relationships among these receptors.  Thus far, the integrins have been 
implicated (Muschler et al., 1999; Slade et al., 1999; Streuli et al., 1991; Weaver et al., 
1997) and, based on indirect evidence, we have postulated an important role for 
dystroglycan (Weir and Muschler, 2003). 
   Dystroglycan (DG) is a heterodimeric glycoprotein encoded by a single gene (DAG1) 
and is located on cell surfaces in most adult tissues (Michele and Campbell, 2003).  It 
consists of a transmembrane β-subunit of 43 kDa and a non-covalently associated, 
extracellular α-subunit of 120-200 kDa (Fig. 1A).  The cytoplasmic domain possess 
known signaling motif and links to the actin cytoskeleton, while the extracellular domain 
is capable of interacting with extracellular matrix (ECM) proteins, such as laminins, 
agrin, and perlecan (Michele and Campbell, 2003).  Binding of DG to laminin-111 occurs 
at the C-terminal globular domains (LG4 -5) of the laminin α subunit (Ervasti and 
Campbell, 1993; Gee et al., 1993) (Fig. 1B).  In skeletal muscle, DG serves as a 
transmembrane link between laminin-2 in the ECM and the intracellular actin 
cytoskeleton, possibly stabilizing the muscle cell membrane (Ervasti and Campbell, 
1993).  In such cells, DG forms part of the dystrophin-glycoprotein complex, and certain 
defects in these components result in distinct muscular dystrophies (Durbeej and 
Campbell, 2002). 
   In some tissues, DG has been shown to play a role in BM formation.  Knockout of DG 
in mice is embryonic lethal, resulting in a lack of laminin recruitment and formational 
defects in Reichert’s membrane, an extra-embryonic BM (Williamson et al., 1997).  In 
DG-/- mouse embryoid bodies, disruption of the BM was seen with an almost total loss in 
laminin cell surface binding (Henry and Campbell, 1998).  In a skeletal muscle cell line, 
laminin-111 and laminin-211 polymerized while interacting with DG and integrins on the 
cell surface, suggesting a model for receptor-facilitated self assembly of laminins 
(Colognato et al., 1999).   
   Several studies have implicated DG in BM-induced epithelial functions, consistent with 
its location on the basolateral surface of epithelial cells contacting the BM, including 
those in the mammary gland (Durbeej et al., 1998).  Based on antibody perturbation 
studies, DG plays a role in epithelial morphogenesis in kidney, lung, and salivary gland 
(Durbeej et al., 1995; Durbeej et al., 2001).  Genetic disruption of dystroglycan 
expression revealed functions in survival of Drosophila epithelial cells (Deng et al., 2003) 
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and epiblasts of embryoid bodies (Li et al., 2002).  DG has been implicated also in 
epithelial polarity by the study in Drosophila (Deng et al., 2003) and by over-expression 
in a tumorigenic human MEC line (Muschler et al., 2002).   
   Since DG knockout in mice is embryonic lethal (Williamson et al., 1997), DG functions 
have not been assessed by genetic means in adult mammalian epithelial cells.  Here we 
have used a genetic approach in cultured cells to investigate DG’s contribution to 
laminin-111-induced epithelial architecture and function.  We examined the effect of a 
DG gene deletion on laminin assembly and laminin-111-induced responses in adult 
mouse MEC lines.  Results presented here demonstrate for the first time that DG serves 
as a critical MEC co-receptor mediating cell responses to the basement membrane that 
include epithelial polarization and β-casein induction.  We also dissect the critical 
receptor domains and demonstrate that DG enacts these signals by anchoring laminin-111 
to the cell surface, thereby facilitating laminin-111 polymerization and subsequent 
signaling.   
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Materials and methods 
Production of immortalized floxed DG mouse MEpG and MEpL cell lines 
Mammary glands from homozygous floxed DG transgenic mice (Moore et al., 2002) 
were digested at 37oC in 0.2% trypsin (Invitrogen), 0.2% collagenase A (Roche), 
DME/F12 (HyClone), 5% FBS (HyClone), 5 μg/mL insulin (Sigma), and 50 μg/mL 
gentamicin (Invitrogen), followed by centrifugation (400xg, 5 s) until fibroblast-free.  
Cells were grown in plastic flasks (MEpG cell line) or collagen I gels (Cellagen; ICN 
Biomedicals) (Kittrell et al., 1992) for 5 weeks prior to collagenase A digestion of the gel 
and cell transfer to plastic flasks (MEpL cell line).  Cells were grown in DME/F12, 2% 
FBS, 10 μg/mL insulin, 5 ng/mL EGF (BD Biosciences), and 50 μg/mL gentamicin 
(=complete media) in humidified 5% CO2 at 37oC and passaged using dispase II (Roche) 
until spontaneously immortalized, after which 0.025% trypsin/0.27 mM EDTA (Cellgro) 
were used.  Clones were obtained by limiting dilution and screened for expression of 
epithelial markers by immunofluorescent staining.  
     
Generation of DG+/+ and partial DG-/- mouse MEC populations 
Adenoviral vectors (Microbix) were amplified twice in QBI-293 packaging cells 
(Quantum Biotechnologies), grown in DMEM (Invitrogen), 2 mM Gln, 10% FBS, and 10 
μg/mL gentamicin.  Immortalized floxed DG mouse MEC lines (MEpG, MEpL) were 
infected with either control (Ad.floxlacZ1) or Cre recombinase-expressing (Ad.creM1) 
adenoviral supernatants with multiplicity of infection of 40-50. 
 
Expression of full length DG and mutants in completely DG-/- MEC lines 
Human DG coding sequence was subcloned from pLXSN vector (Muschler et al., 2002) 
into the EcoRI site of the retroviral expression vector, pBMN-IRES-PURO (Kinoshita et 
al., 1997).  From this construct, β-DG cytoplasmic deletion mutants were constructed 
using the QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) and verified by 
sequencing.  DEL A, B, C, D, and E lacked amino acids 780-895, 806-880, and 881-895, 
315-485, and 400-485, respectively (Fig. S3).  DG-tmf was constructed from the ligation 
of 2 PCR products spanning amino acids 1-739 of DG, and amino acids 656-699 of the 
human TACE gene.  The reverse primer for the TACE PCR product included the coding 
sequence for 10 aditional amino acids at the C-terminus (LDEESILKQE), representing 
the Myc tag.  Retrovirus was generated using Phoenix-ECO packaging cells grown in 
DME/H21 (UCSF Cell Culture Facility) and 10% FBS and transfected using calcium 
phosphate (Sambrook et al., 1989).   
   DG-/- clones were obtained by limiting dilution of partial DG-/- MEC populations and 
screened by immunostaining for lack of DG expression.  Clones were seeded in 100 mm 
dishes, infected with 2 mL of retroviral supernatant, 6 mL of complete media, and 8 
μg/mL polybrene, and selected in complete media with 5-10 μg/mL puromycin (Sigma).     
  
3-D polarity assays 
Trypsinized cells (~104 - 105) were added to 300 uL of collagen I (Cellagen; ICN 
Biomedicals) or collagen I/laminin-111 (35 μg; Sigma) on ice.  Matrices were solidified 
at 37oC and covered with complete media with changes every 2 d.  On d 6 or 7, samples 
were immunostained.  For polarity quantification, colonies with >3 nuclei were 
considered polar if ZO-1 staining was centrally located within the colony.  For statistical 
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analysis, comparisons between groups were subject to one way analysis of variance and 
differences between means were determined using Fisher’s least significant difference 
method. 
 
β-casein and laminin assembly assays 
β-casein assays were performed as previously described (Muschler et al., 1999), except 
that 5 μg/mL prolactin and serum-free complete media were used.  To assess laminin 
assembly, laminin-111-FITC was prepared by dialysing laminin-111 (Sigma) in PBS, 10 
μM CaCl2, and incubating with NHS-fluorescein (Pierce) for 2 h at 4oC in the dark.  
Dialysis was repeated, and laminin-111-FITC was measured by the Lowry protein assay 
(Peterson, 1977).  Laminin-111 was treated with AEBSF (Calbiochem) as described 
(Colognato et al., 1999).  Cells grown on Lab-Tek II CC2 glass chamber slides (Nalge 
Nunc) were immunostained following incubation at 37oC in the dark in serum-free 
complete media with 10 nM AEBSF-treated laminin-111 for 24 h or 10 nM laminin-111-
FITC for 4 or 24 h (latter with or without integrin function-blocking antibodies).   
 
Immunofluorescent staining  
Cells grown on Lab-Tek II CC2 glass chamber slides (Nalge Nunc) or in 3-D polarity 
assays were washed twice in PBS.  Some 3-D samples were digested with 0.2% 
collagenase A in complete media at 37oC to remove matrix for easier counting.  For 
actin/α6 integrin, DG, and laminin staining, samples were fixed in 2% formaldehyde in 
PBS for 10 min, RT and washed in PBS, 25 mM glycine for 3x10 min.  For ZO-1/α6 
integrin staining, samples were fixed in acetone/methanol (1:1) at -20oC for 5 min and 
air-dried.  After blocking in PBS, 10% goat serum (Sigma), 0.1% Tween-20 for 1 h, RT, 
samples were incubated in blocking solution overnight at 4oC with primary antibodies, 
followed by 1 h, RT with fluorescent secondary antibodies.  For actin staining, Alexa 
Fluor 488 phalloidin (Molecular Probes) was used for 20 min, RT using 1:21 dilution in 
blocking solution.  Nuclei were counterstained with 10 μg/mL propidium iodide (Sigma).  
Washes between antibody incubations were 3x10 min in PBS.  Samples were mounted in 
Vectashield mounting media (Vector Laboratories) with glass coverslips. 
 
Microscopy      
Immunofluorescent images were obtained with a Nikon Eclipse TE2000-U inverted 
microscope, Photometrics CoolSNAP HQ camera, MetaMorph 6.1r1 software (Universal 
Imaging Corporation), and a Nikon Plan Ph1 DL 20X objective (0.40 NA) (Fig. 4C inset 
obtained with Nikon Plan Apo DIC H 60X oil objective of 1.40 NA).  Confocal images 
were obtained with the same microscope and a Nikon D-Eclipse C1 confocal attachment, 
Nikon EZ-C1 2.10 software, channel series setup, and the 60X oil objective.  Images 
were cropped and adjusted for contrast using Adobe Photoshop 7. 
 
Western blots 
Cell extracts were prepared in 62.6 mM Tris-HCl, pH 6.8, 2% SDS, 5% glycerol, 5 
μg/mL pepstatin (Sigma), 500 μM AEBSF, 150 nM aprotinin, 1 μM E-64, 0.5 mM 
EDTA, 1 μM leupeptin (all from Calbiochem) and measured using the Lowry protein 
assay (Peterson, 1977).  SDS-PAGE was performed under reducing conditions using 
equal amounts of protein and 4-12% or 4-20% polyacrylamide Tris-glycine gradient gels.  
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Proteins were electrophoretically transferred to Immobilon-P membranes (Millipore).  
Blots were blocked in 5% non-fat dry milk in TBS-T (50 mM Tris-HCl, pH 7.4, 100 mM 
NaCl, 0.1% Tween-20) for 1 h, RT, followed by incubation in blocking buffer overnight 
at 4oC with primary antibodies, then 1 h, RT with HRP-conjugated secondary antibodies..  
Blots were washed in TBS-T after antibody incubations, and bands were visualized with 
the ECL/ECL Plus systems (Amersham Pharmacia). 
 
Antibodies 
Mouse mAbs specific for C-terminal β-DG (NCL-b-DG; Novocastra), N-terminal β-DG 
(BD Biosciences), E-cadherin (BD Transduction Labs), and β-casein (Kaetzel and Ray, 
1984) were used for immunoblotting at 1:200, 1:500, 1:5000, and 1:2000, respectively.  
The former antibody was used for immunostaining at 1:50.  Rabbit pAbs specific for ZO-
1 (Zymed) or laminin purified from the BM of Engelbreth-Holm-Swarm mouse sarcoma 
(Sigma) were used for immunostaining at 1:100 and 1:40, respectively.  Rat mAb GoH3 
specific for α6 integrin (Chemicon) was used for immunostaining at 1:30.  Mouse IgM 
mAb IIH6C4 specific for α-DG (Ervasti and Campbell, 1991) (Upstate, Inc.) was used 
for immunostaining at 1:200 and immunoblotting at 1:300.  Function blocking antibodies 
for α6 and β1 integrins were used at 10 and 50 μg/mL, respectively (PharMingen).  The 
anti-α6 antibody was later tested at 100 μg/ml, and produced the same result.  
   Cy-5-, FITC-, or rhodamine-conjugated, affinity-absorbed antibodies specific for 
mouse, rat, or rabbit IgG and mouse IgM (Amersham Pharmacia; Chemicon; Caltag) 
were used at a 1:50 dilution.  HRP-conjugated antibodies specific for mouse IgG 
(Amersham Pharmacia) and mouse IgM (Sigma) were used for Western blots at 1:2000 
and 1:3000, respectively. 
 
Online supplemental material 
Fig. S1. Established cell lines display epithelial markers before and after adenoviral 
infection.  Monolayers of uninfected MEpG cells (left panel) or those infected with either 
a control or Cre-expressing adenovirus to generate DG+/+ cells (middle panel) or DG-/- 
cells (right panel), respectively, were fixed in acetone/methanol and immunostained as 
described in Materials and methods.  Mouse mAb specific for E-cadherin (BD 
Transduction Labs) was used at 1:200.  Rat mAb TROMA-1 specific for keratin 8 was 
used at 1:30 (obtained from Developmental Studies Hybridoma Bank under the auspices 
of the NICHD; maintained by University of Iowa, Dept. of Biol. Sciences, Iowa City, IA) 
(Kemler et al., 1981).  Both of the former antibodies were visualized with FITC-
conjugated secondary antibodies (green).  Rabbit pAb specific for ZO-1 (Zymed) was 
used at 1:100 and detected with rhodamine-conjugated secondary antibody (red).  Images 
were captured using a Nikon Eclipse E800 microscope, SPOT camera (Diagnostic 
Instruments Inc), Image-Pro Plus 3.0.01.00 software (Media Cybernetics), and a Nikon 
Plan Fluor Ph1 DLL 20X objective (0.50 NA).  Bar, 60 μm. 
   Fig. S2. DG protein levels in DG+/+ and partial DG-/- MEC populations generated by 
adenoviral infection of the MEpL cell line.  Shown in A is a Western blot of cell extracts 
(10 μg protein) prepared on various days after infection of immortalized floxed DG 
mouse MEpL cell line with control or Cre recombinase-expressing adenovirus to 
generate DG+/+ or partial DG-/- cell populations, respectively.  Lane 1 represents 
uninfected cells at time 0.  Antibodies are described in the legend for Fig. 1.  Sizes of 
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molecular weight markers are given in kDa.  Shown in B are vertically paired 
immunofluorescent images of DG+/+ and partial DG-/- cell populations that were stained 
using a C-terminal β-DG antibody followed by a FITC-labeled secondary antibody 
(upper panel).  Nuclei were stained with propidium iodide (bottom panel).  Bar, 60 μm. 
   Fig. S3. Diagram of DG mutants.  Shown are the structures of full length DG (wtDG), 
deletion mutants (DEL A, B, C, D, and E) and the transmembrane fusion mutant (DG-
tmf), consisting of extracellular DG sequences fused to the transmembrane domain of 
TACE.  Numbers refer to amino acids in human α- and β-DG, with deleted sequences 
shown by dotted lines.  “PM” refers to the plasma membrane.”TM” refers to the 






Establishment of DG+/+ and partial DG-/- mouse MEC populations 
In order to assess DG function in adult mouse MECs, a culture system was developed in 
which DG gene expression could be conditionally abrogated using Cre-lox 
recombination. We established two spontaneously immortalized MEC lines, MEpG and 
MEpL (Mammary Epithelial clones G and L), from mammary glands of floxed DG 
transgenic mice (see Materials and Methods).  Infection of these cells with Cre 
recombinase-expressing adenovirus resulted in recombination between loxP sites 
flanking exon 2 of the DG gene, subsequent DG gene inactivation, and creation of DG-/- 
MECs.  
   Both MEpG and MEpL cell lines were epithelial in nature, as judged by tightly packed, 
cobblestone-like morphologies and expression of typical MEC markers; 
immunodetection revealed expression of epithelial ZO-1, E-cadherin, and keratin 8 (Fig. 
S1, left panel), but not myoepithelial α-smooth muscle actin or vimentin (data not 
shown).  The MEpG cell line was used for laminin assembly and polarity assays; these 
cells did not express β-casein.  The MEpL cell line was used for laminin assembly and β-
casein assays, but not for polarity analyses.  Many MEpL colonies produced pseudopod-
like extensions when grown in 3-D matrices, making assessment of polarization difficult.     
   Infection of the MEpG cell line with control adenovirus produced a control DG+/+ cell 
population which retained expression of DG protein over time, as shown by Western 
blotting (Fig. 1C) and immunostaining (Fig. 1D) for α- and β-DG.  Parallel infection of 
the MEpG cell line with Cre recombinase-expressing adenovirus, to produce a DG-/- cell 
population, resulted in a near complete loss of DG protein expression, as demonstrated by 
Western blotting for α- and β-DG (Fig. 1C).  Immunostaining revealed that about 90% of 
the Cre-infected MECs lacked α- and β-DG expression (Fig. 1D).  Similar results were 
obtained upon adenoviral infection of the MEpL cell line (Fig. S2).  DG+/+ and partial 
DG-/- cell populations retained the epithelial marker expression profile seen in MEpG 
and MEpL parent cell lines prior to adenoviral exposure, showing that neither viral 
infection nor DG loss altered the epithelial phenotype (Fig. S1 and data not shown).  
 
DG loss and MEC polarity  
To investigate the role of DG in laminin-111-induced MEC polarization, DG+/+ and 
partial DG-/- cell populations were grown in 3-D matrices containing collagen-1 with or 
without laminin-111, established culture models that can mimic the in vivo MEC 
response to the BM microenvironment.  Polarity was assessed by examining the 
distribution of ZO-1, α6 integrin, nuclei, and cytoskeletal actin. 
   Immunofluorescent staining of DG+/+ and DG-/- colonies grown in collagen I revealed 
a random distribution of nuclei, ZO-1 and α6 integrin (Fig. 2A, upper panel).  Actin and 
DG (latter in DG+/+ cells only) showed apolar patterns similar to α6 integrin (Fig. 2B, 
upper panel).  Quantification of polarization using ZO-1 staining revealed few polar 
DG+/+ or DG-/- colonies in collagen I (Fig. 2C). 
   When laminin-111, a known inducer of polarization of mammary gland acini, was 
added to the collagen I matrix, DG+/+ cells polarized, displaying dramatic changes in the 
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distribution of polarity markers and the cytoskeleton (bottom left images in Fig. 2A, B).  
ZO-1 and actin were found at the center of colonies, consistent with apical formation of 
tight junctions and an underlying cytoplasmic actin belt.  DG and α6 integrin were 
localized basolaterally on cell surfaces and nuclei shifted to the colony periphery.  
Quantification using ZO-1 staining revealed a significant increase in polarized colonies in 
collagen I/laminin-111 compared to collagen I alone (35.3% vs. 8.0%, P<0.01; Fig. 2C). 
   Unlike DG+/+ cells, DG-/- cells did not significantly polarize in collagen I/laminin-111 
(bottom right images in Fig. 2A, B), exhibiting polarization levels similar to those seen in 
collagen I (Fig. 2C).  Increasing laminin-111 from 35 to 75 μg in the collagen matrix did 
not elevate polarization of DG+/+ or DG-/- cells further (data not shown).  The inability 
of DG-/- cells to polarize in response to laminin-111 was not due to a problem in tight 
junction formation, since ZO-1 still localized at cell-cell contacts in confluent monolayers 
of DG-/- cells grown on plastic (Fig. S1, right middle panel). 
 
DG links laminin assembly and MEC polarity 
DG has been implicated in laminin assembly in a few cell types (Colognato et al., 1999; 
Henry and Campbell, 1998; Williamson et al., 1997), but such a role in differentiated 
epithelial cells has not been investigated.  To test the hypothesis that DG-/- MECs failed 
to polarize in response to laminin-111 because of laminin assembly defects, DG+/+ and 
DG-/- cells in 3-D polarity assays were immunostained using a polyclonal antibody 
raised against laminin-111 subunits. 
   Apolar DG+/+ cells in collagen I showed punctate patterns, small patches, and 
polygonal arrays of endogenously produced laminin on colonies’ outer surfaces (Fig. 3A, 
left of top panel), which co-localized with DG in many regions (Fig. 3B, top panel).  
Apolar DG-/- cells in collagen I lacked laminin surface staining (Fig. 3A, right of top 
panel).  Importantly, in collagen I/laminin-111 gels, polarized DG+/+ cells had an 
extensive laminin network on colonies’ outer surfaces (Fig. 3A, left of 3rd panel), which 
co-localized with DG as a more continuous polygonal array than seen in collagen I alone 
(Fig. 3B, bottom panel).  In contrast, apolar DG-/- cells in collagen I/laminin-111 were 
deficient in laminin surface staining (Fig. 3A, right of 3rd panel).    
   In order to determine if the observed lack of laminin staining on DG-/- cells was unique 
to the 3-D ECM environment, laminin assembly was examined further using cell 
monolayers.  Staining of DG+/+ cells for endogenous laminin revealed a diffuse, 
intracellular component and a punctate, extracellular pattern (Fig. 4A, left images above 
line).  In contrast, cells lacking DG in the partial DG-/- cell population exhibited 
intracellular, but not extracellular, laminin staining (Fig. 4A, right images above line).  
Laminin locations were confirmed by using unpermeabilized cells where only 
extracellular laminin staining was visible due to lack of intracellular access by the anti-
laminin antibody (Fig. 4A, images below line).     
   To observe the assembly of laminin-111 exclusively, cells were exposed to exogenous 
laminin-111-FITC for 4 h and imaged without the use of antibodies.  Examination of 
DG+/+ cell monolayers revealed punctate patterns and extensive patches of surface 
laminin-111-FITC (Fig. 4B, left panel).  This binding was found to be time- and 
concentration-dependent with initial punctate patterns evolving into progressively larger, 
connected patches (data not shown).  In contrast, cells lacking DG in the partial DG-/- 
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cell population did not show laminin binding at any time (4-24 h) or even at a high 
concentration of 10 nM laminin-111-FITC (Fig. 4B, right panel; data not shown).   
     These findings demonstrate that DG-/- cells retain the ability to synthesize laminin, 
but are unable to bind endogenous laminins or exogenous laminin-111 either in 
monolayers or within a 3-D matrix.  Hence, DG serves as the critical link between 
laminin-111 interaction with MECs and subsequent induction of polarization in a 3-D 
environment. 
     To test whether DG and integrins cooperate in laminin assembly in MECs, we 
employed integrin function-blocking antibodies.  DG+/+ cells were exposed to laminin-
111-FITC for 24 h, a time at which extensive polymerization had occurred (Fig. 4C, left 
panel).  Blocking of α6 integrins had no effect on laminin-111 assembly (Fig. 4C, 2nd 
panel from left).  However, inhibition of β1 integrins severely diminished the extent of 
laminin-111 polymerization, but still allowed laminin cell-surface binding (Fig. 4C, 3rd 
panel from left).  This pattern was similar to that seen when DG+/+ cells were incubated 
with non-polymerizing laminin-111 and immunostained for laminin (Fig. 4C, insets in 3rd 
panel from left).  This laminin was generated by treatment with p-
aminoethylbenzenesulfonyl fluoride (AEBSF) (Colognato et al., 1999).  Inclusion of both 
α6 and β1 integrin blocking antibodies produced a result similar to that seen with the β1 
antibody alone (Fig. 4C, right panel).  These findings show that DG and β1 integrins 
cooperate in laminin-111 assembly on MECs, with DG serving as the initial binding site 
enabling β1 integrins to participate in subsequent polymerization and signaling.   
 
Chimeric MEC colonies do not polarize   
Cues for epithelial polarization originate from the BM and neighboring cells (Yeaman et 
al., 1999).  To determine whether DG influences polarization of neighboring cells and the 
minimal number of DG expressors required for colony polarization, we analyzed the 
polarity of chimeric colonies containing both DG+/+ and DG-/- cells.  Such colonies 
were produced in polarity assays using the partial DG-/- MEpG population, which 
contained a subpopulation of DG+/+ cells (Fig. 1).  Staining of chimeric colonies in 
collagen I/laminin-111 for actin and α6 integrin revealed an apolar phenotype, even when 
half or more of the cells in the colony were DG+/+ (Fig. 5A).  Quantification using α6 
integrin staining showed minimal levels of overall polarization in chimeric colonies even 
when the majority of cells in a colony were DG expressing (avg.+std.dev.= 0.98+1.34%;  
n=5 counts x 40 colonies per count).  Interestingly, laminin staining was visible only on 
the surface of DG+/+ cells, where it co-localized with DG in an extensive reticular 
network (Fig. 5B, C).  These observations suggest that global DG expression in MEC 
colonies is essential in order for laminin-111 to assemble around the entire colony and 
trigger cooperative participation of all cells in colony polarization. 
 
DG loss disrupts β-casein production in MECs 
Previous results indicated that BM-induced β-casein expression in MECs required β1 
integrins, α6β4 integrin, and a laminin receptor binding the LG4-5 domains (Faraldo et 
al., 1998; Muschler et al., 1999; Streuli et al., 1991).  To determine directly the role of 
DG in laminin-111-induced β-casein production, DG+/+ and partial DG-/- MEC 
populations (derived from the MEpL cell line) were tested in β-casein assays using 
lactogenic hormones and a laminin-111 overlay (Streuli et al., 1995). 
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   DG+/+ and the partial DG-/- cell populations produced β-casein protein in response to 
laminin-111 in the presence, but not absence, of lactogenic hormones, as expected (Fig. 
6A).  However, the partial DG-/- cell population showed a drastic reduction in laminin-
111-induced β-casein levels.  As expected, no β-casein was detected in either cell 
population upon omission of the laminin-111 overlay (Fig. 6A).   
   Analysis of the ability of DG+/+ and partial DG-/- cells to bind laminin revealed results 
similar to those seen with the MEpG cell line (Fig. 4).  DG+/+, but not DG-/-, cell 
monolayers bound endogenous laminins (data not shown) and exogenous laminin-111-
FITC (Fig. 6B).  These results show that the decrease in laminin-111-induced β-casein 
levels in the partial DG-/- cell population is due to disruption of laminin-111 binding to 
DG-/- cells.  
 
The DG extracellular domain alone is critical to laminin assembly. 
The β-subunit of DG contains cytoplasmic sites potentially recognized by SH3, SH2, and 
WW domain proteins (Ibraghimov-Beskrovnaya et al., 1992; Pawson, 2004).  To 
investigate whether DG plays an active signaling role in MEC functions, three β-DG 
cytoplasmic domain deletions were generated and tested (Fig. S3).  DEL A lacked the 
entire cytoplasmic domain, except for six amino acids beyond the transmembrane region.  
DEL B had an internal deletion resulting in retention of the C-terminal 15 amino acids 
and proximal removal of several potential WW, SH3, and SH2 domain protein 
recognition sites.  DEL C lacked the C-terminal 15 amino acids, which contain proven 
interaction sites for SH3, SH2, and WW domain proteins (Ilsley et al., 2002; Sotgia et al., 
2001; Yang et al., 1995).   
   We generated a completely DG-/- cell line by single cell cloning from the partially DG-
/- MEpG cell population and then infected the DG-/- cell line with either empty retroviral 
vector (VEC) or vector encoding full length DG (wtDG), DEL A, DEL B, or DEL C.  
Western blots showed that VEC cells were deficient in α- and β-DG protein (Fig. 7A, left 
panels), whereas the other infected cells expressed α-DG of the same size as in DG+/+ 
cells (Fig. 7A, upper left panel).  An N-terminal β-DG antibody verified expression of the 
full length β-subunit in wtDG cells and truncated versions in DG mutant cells (Fig. 7A, 
upper right panel).  A β-DG antibody recognizing an epitope in the C-terminal 15 amino 
acids detected the β-subunit in wtDG and DEL B cells, but not in DEL A or C cells, 
verifying the lack of this epitope in the latter two populations (Fig. 7A, middle left panel). 
   α-DG was correctly localized to the surface of wtDG and DG mutant cells and was not 
detected on VEC cells (Fig. 7B).  Laminin-111-FITC bound and assembled at the surface 
of wtDG, but not VEC, cells, showing that DG re-expression corrected the laminin 
assembly defects (Fig. 7C).  All DG mutant cells also assembled cell surface laminin-
111-FITC comparable to wtDG cells, revealing, surprisingly, that DG cytoplasmic 
domains were not required (Fig. 7C).  Identical results were obtained upon expressing 
wtDG or DG mutants in DG-/- cells derived from the MEpL cell line (data not shown). 
   Analysis of laminin-111-induced polarity in VEC, wtDG, and DG mutant cells 
demonstrated very few polar colonies in collagen I (Fig. 8A, top panel; 8B).  Addition of 
laminin-111 to the collagen I gel resulted in significant increases in the number of polar 
colonies for all but the DG-/- (VEC) cells (Fig. 8A, middle panel; 8B).  In addition, 
immunostaining revealed laminin localization on colony surfaces of all but VEC cells 
grown in collagen I/laminin-111 (Fig. 8A, bottom panel). Likewise, laminin-111-induced 
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β-casein levels were restored in wtDG and DG mutant cells compared to VEC cells (Fig. 
9).  However, even in the complete absence of DG expression, low levels of β-casein 
were seen in VEC cells treated with laminin-111.  As in Fig. 6A, no β-casein was 
detected in any of the cell populations in the absence of a BM overlay.    
   Additional DG mutants were created to investigate the role of DG transmembrane and 
extracellular domain sequences in laminin assembly (Figure S3).  The DG  cytoplasmic 
and transmembrane domains were replaced by 44 amino acids encompassing the 
transmembrane domain of the “TNF-α cleaving enzyme” (TACE) (Moss et al., 1997), 
plus an unrelated 10 amino acid cytoplasmic tail. When expressed in the DG-/-  MEpL 
cells, this fusion protein (DG-tmf) permitted laminin anchoring and assembly (Fig. 10).   
A mutant possessing a large deletion in the C-terminal half of the mucin domain (DEL E) 
also functioned like the wild-type protein.  Importantly, only expression of a DG cDNA 




Laminins are key signaling modulators of cellular architecture and function during 
embryonic and post-natal development (Li et al., 2003; Miner and Yurchenco, 2004).  In 
mammary epithelial cells, laminin-111 interaction with cell surface receptors is important 
for induction and retention of differentiated features, including cellular and tissue polarity 
and β-casein expression (Gudjonsson et al., 2002; Slade et al., 1999; Streuli et al., 1995).  
Using a DG genetic deletion in adult MEC lines, we show here that DG plays a crucial 
role as a laminin-111 co-receptor in MEC functions, acting at an initial and critical step 
(see model, Fig. 11).  We demonstrate that DG mediates laminin-111 anchoring to the 
MEC surface, such that subsequent laminin-111 polymerization and induction of signals 
linked to polarity and β-casein levels can proceed via other co-receptors.   
 
Role of DG in laminin assembly 
Although most laminins self-assemble spontaneously, the process is facilitated by 
interaction with cell surface receptors.  This mechanism involves receptor binding of 
monomeric laminin via its C-terminal G domain and laminin polymerization via resultant 
interactions between neighboring N-terminal short arms (Colognato et al., 1999).  This 
polymerization is crucial for recruitment of other BM proteins, cytoskeletal 
reorganization, and signaling events (Colognato et al., 1999).   
   Data presented here demonstrate in an adult epithelial cell type (MECs) that DG and β1 
integrins cooperate in receptor-facilitated laminin assembly.  Significantly, we find that 
DG is essential for initial laminin-111 binding to MECs such that subsequent 
polymerization can proceed via β1-integrin co-receptors.  These results help to explain 
BM defects seen upon DG reduction or loss in brain cells, Reichert’s membrane, and 
Drosophila epithelia (Deng et al., 2003; Michele et al., 2002; Moore et al., 2002; 
Williamson et al., 1997).  They also support observations made using embryonic stem 
cells cultured in monolayer (Henry and Campbell, 1998; Henry et al., 2001b; Lohikangas 
et al., 2001).  However, the requirement for DG in laminin/BM assembly may be tissue-
specific.  In one study, assays for BM assembly in ES-derived embryoid bodies show no 
BM defects in DG-/- embryoid bodies, but show a dramatic loss of epiblast cell survival 
(Li et al., 2002), although another study shows loss of laminin and BM assembly in DG-/- 
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embryoid bodies produced by a method that did not generate a differentiated epiblast 
layer (Henry and Campbell, 1998).  In addition, normal BMs are observed upon DG loss 
in skeletal muscle and some embryonic tissues (Cohn et al., 2002; Michele et al., 2002; 
Williamson et al., 1997).  In Schwann cells and fibroblasts, certain sulfated glycolipids 
can mediate laminin/BM assembly (Li et al., 2005), raising the possibility that DG and 
sulfated glycolipids may functionally overlap.       
Because DG can mediate laminin assembly and signaling in the absence of 
endogenous transmembrane and cytoplasmic signaling domains, and also function in the 
presence of a large internal deletion of the extracellular domain, it appears that laminin 
anchoring to the cell surface is the main, and possibly only, role for DG in the initiation 
of assembly and signaling.  This model is consistent with observations in fibroblasts and 
Schwann cells showing that laminin binding to cell-surface glycolipids is also sufficient 
to initate assembly and signaling (Li et al., 2005).  Importantly, no exogenous laminin-
111 binding was observed at the surface of DG-/- cells, demonstrating that no other 
molecule compensated for DG’s role in laminin anchoring to MECs.  This result also 
suggests that co-receptors, such as the β1 integrins require the interaction of DG with 
laminin-111 prior to recruitment and/or activation.   A recent study in intestinal epithelial 
cells reported direct interaction of DG and β1 integrins by co-immunoprecipitation (Driss 
et al., 2005), something we have not yet observed in MECs.  This same study also 
reported an enhancement of integrin-laminin-111 interactions that is dependent on DG 
cytoplasmic sequences, but this observation is inconsistent with our results in MECs, 
where deletion of DG cytoplasmic sequences did not perturb function. 
    
DG mediates signals for epithelial architecture and function. 
Our results show that DG also plays an essential role in mediating laminin-111-induced 
MEC functions, including tissue architecture and tissue-specific gene expression.  DG-/- 
cells failed to polarize and showed markedly reduced β-casein production because of 
defects in laminin-111 binding.  In addition, our finding that laminin-111/DG signaling 
pathways linked to polarity and β-casein levels were independent of β-DG cytoplasmic 
domains suggests that the functional coupling of DG with co-receptors enacts signaling.  
Candidate co-receptors include α6β4 or β1 integrins that influence polarity (Faraldo et 
al., 1998; Slade et al., 1999; Weaver et al., 1997) and β-casein levels (Faraldo et al., 
1998; Muschler et al., 1999; Streuli et al., 1991).  A partial, albeit low, receptor 
compensation for DG loss was seen in laminin-111-induced β-casein assays, suggesting 
that, in the presence of high laminin-111 levels, some spontaneous laminin self-assembly 
may take place, or interaction with a less effective laminin receptor may occur.  Whatever 
the case, DG is still needed as a laminin-111 co-receptor to allow efficient β-casein 
production.   
      The results reported here provide a molecular mechanism to explain why 
overexpression of DG is capable of reverting and normalizing breast tumor cells, and 
why the functional status of DG correlates strongly with a tumor cells ability to polarize 
(Muschler et al., 2002).  In addition, they explain the observed requirement for multiple 
MEC receptors in β-casein expression, including a receptor for the laminin LG4-5 
domain that is likely to be DG (Muschler et al., 1999; Streuli et al., 1995).  The results 
can also explain the role of DG in establishing Drosophila epithelial polarity (Deng et al., 
2003).  However, DG knockout in mouse embryoid bodies does not affect polarization of 
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epiblast cells (Li et al., 2002) demonstrating that DG is not universally required for 
polarity in mammalian cells.   Epiblast differentiation and polarization are affected in 
mice lacking the laminin α1 LG4-5 modules, hinting at the existence of other receptors 
for these modules (Scheele et al., 2005). 
Our observation that MEC chimeras of DG expressors and non-expressors did not 
polarize stresses the importance of laminin assembly along the entire basal epithelial 
surface to establish normal tissue architecture; loss of laminin assembly on even a 
minority of cells is sufficient to disrupt polarity in the entire acinar structure.  This result 
illustrates the required integration of both cell-cell and cell-BM interactions to establish 
cellular and tissue polarity (Yeaman et al., 1999).  DG-/- cells of chimeric colonies 
lacked the ability to bind surface laminin-111 and did not receive the necessary external 
BM cue for activation of intracellular polarity pathways, which include establishing of 
proper cell-cell junctions.  Consequently, with direct contact of DG+/+ cells and DG-/- 
cells, the defect of the DG-/- cells was dominant.  This defect was sufficient to prevent 
the establishment of polarity in DG+/+ cells, and was propagated throughout the colony. 
 
DG’s significance in vivo and in disease 
   Our findings have important implications for understanding the abnormal behavior of 
carcinomas of the breast and other tissues.  In breast, prostate, and colon cancers, loss in 
DG detection correlates with tumor progression (Henry et al., 2001a; Sgambato et al., 
2003).  In many carcinoma cell lines, including those of the breast, DG lacks laminin 
binding ability due to glycosylation changes and/or proteolytic processing (Losasso et al., 
2000; Muschler et al., 2002; Singh et al., 2004).  Our results reveal that localized 
disruption of the DG/laminin-111 link in MECs leads to losses in laminin-111-induced 
responses important to normal epithelial architecture and function, with impact on 
neighboring cells as well.  Thus, loss of DG function is a plausible and attractive 
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Figure 1.  Generation of DG+/+ and partial DG-/- MEC populations by adenoviral 
infection of immortalized mouse MECs.  A) Diagram of DG, including the 
extracellular α-DG subunit, with central mucin domain, and the transmembrane β-DG 
subunit.  B)  Diagram of laminin-111 (LN), including the 3 subunits (α, β, γ), and the 5 
C-terminal LG domains, with respective receptor binding sites.  C) Western blot of cell 
extracts (5 μg protein) prepared on various days after infection of immortalized floxed 
DG mouse MEpG cell line with control or Cre recombinase-expressing adenovirus to 
generate DG+/+ and partial DG-/- cell populations, respectively.  Lane 1 represents 
uninfected cells at time 0.  Blots were incubated with antibodies specific for α-DG, C-
terminal β-DG, or E-cadherin (loading control), followed by HRP-conjugated secondary 
antibodies.  Sizes of molecular weight markers are shown in kDa.  D) Vertically paired 
immunofluorescent images of DG+/+ and partial DG-/- cell populations using primary 
antibodies specific for α-DG or C-terminal β-DG, followed by FITC-labeled secondary 
antibodies (upper panel).  Nuclei were stained with propidium iodide (bottom panel).  
Bar, 60 μm.  
 
Figure 2.  Loss of polarity in DG-/- colonies grown in a 3-D matrix of collagen 
I/laminin-111.  DG+/+ and DG-/- cells were grown in a 3-D matrix of collagen I or 
collagen I/laminin-111  and co-immunostained.  Confocal immunofluorescent images 
were taken at colony centers.  Bar, 10 μm.  A) Staining using ZO-1 and α6 integrin 
antibodies, visualized with FITC- (green) and Cy-5- (blue) labeled secondary antibodies, 
respectively, and propidium iodide to stain nuclei (red).  B) Staining using α6 integrin 
and C-terminal β-DG (insets) antibodies, detected with rhodamine- (red) and Cy-5- (blue 
changed to white for easier visualization) labeled secondary antibodies, respectively.  
Actin was seen using Alexa Fluor 488 phalloidin (green).  Overlap between actin and α6 
integrin staining appeared yellow.  C) Quantification of polarity in DG+/+ and DG-/- 
colonies grown in collagen I (C) or collagen I/laminin-111 (C/L) using ZO-1 as a polarity 
marker.  Results are shown as the average + SEM of 4-6 independent experiments, each 
with triplicate or quadruplicate counts.  * P<0.01 for all paired combinations. 
 
Figure 3.  Loss of laminin binding and DG co-localization on the surface of DG-/- 
cells grown in a 3-D matrix of collagen I or collagen I/laminin-111.  A) Vertically 
paired confocal immunofluorescent images of DG+/+ and DG-/- cells grown in collagen I 
or collagen I/laminin-111.  Samples were co-immunostained with laminin, α6 integrin, 
and C-terminal β-DG (insets) antibodies, followed by rhodamine- (red), FITC- (green), 
and Cy-5- (blue changed to white for easier visualization) labelled secondary antibodies, 
respectively.  Images were taken at colony centers.  B) Confocal immunofluorescent 
images taken at the cell surface of DG+/+ colonies shown in A to reveal co-staining for 
laminin, β-DG, and their extent of co-localization.  Arrows point to polygonal arrays of 
laminin.  Bar, 10 μm. 
 
Figure 4.  DG-/- cell monolayers failed to bind endogenous laminin or exogenous 
laminin-111-FITC.  A) Vertically paired immunofluorescent images of DG+/+ and 
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partial DG-/- cell populations co-stained using laminin and C-terminal β-DG antibodies, 
followed by rhodamine- and FITC-labelled secondary antibodies, respectively, all in the 
presence of Tween-20 (images above line).  Arrows point to a DG-/- cell that retained 
staining for intracellular, but not cell surface, laminin.  Cells immunostained for laminin 
in the absence of Tween-20 are shown below the line, with corresponding phase images.  
B) Immunofluorescent images of DG+/+ and partial DG-/- cell populations treated with 
10 nM exogenously added laminin-111-FITC for 4 h.  Samples were co-stained using C-
terminal β-DG antibody and rhodamine-labelled secondary antibody.  Corresponding 
phase images are shown in the bottom panel.  Arrows point to a DG-/- cell lacking 
laminin-111-FITC staining.  C) Immunofluorescent images of DG+/+ cells treated with 
10 nM exogenous laminin-111-FITC for 24 h in the absence or presence of α6 and/or β1 
integrin function blocking antibodies (upper panel).  Corresponding phase images are 
shown in the bottom panel.  Insets show cells incubated only with 10 nM AEBSF-treated 
laminin-111 for 24 h, followed by immunostaining for laminin as described for upper 
images in A.  Bars, 10 μm. 
 
Figure 5.  Partial DG+/+ colonies grown in a 3-D matrix of collagen I/laminin-111 
retain laminin and DG co-localization on the surface of DG +/+ cells only, but fail to 
polarize.  A) and B) Confocal immunofluorescent images taken at the center of partial 
DG+/+ colonies grown in collagen I/laminin-111 and co-immunostained as follows: A) 
α6 integrin and C-terminal β-DG antibodies were detected using rhodamine- (red) and 
Cy-5- (blue) labelled secondary antibodies, respectively.  Actin was visualized with 
Alexa Fluor 488 phalloidin (green).  B) Laminin, α6 integrin, and C-terminal β-DG 
antibodies were detected using rhodamine- (red), FITC- (green), and Cy-5- (blue) 
labelled secondary antibodies, respectively.  Arrows show part of colony surface lacking 
laminin and β-DG staining.  C) Confocal immunofluorescent images were taken at the 
cell surface of the colony shown in B to reveal co-staining for laminin, β-DG, and their 
extent of co-localization.  Dotted outline represents outer edge of colony.  Bar, 10 μm. 
  
Figure 6.  Loss of β-casein production in response to laminin-111 in DG-/- cells.  A) 
Western blot of cell extracts (10 μg protein) prepared from DG+/+ and partial DG-/- cell 
population incubated with laminin-111 overlay in the absence (-) or presence (+) of 
prolactin and hydrocortisone.  Blots were incubated with antibodies specific for β-casein 
or E-cadherin (loading control), followed by HRP-conjugated secondary antibodies.  
Sizes of molecular weight markers are shown in kDa.  Dotted lines separate non-adjacent 
lanes derived from the same blot.  B) Immunofluorescent images of DG+/+ and partial 
DG-/- cell population treated with 10 nM exogenously added laminin-111-FITC for 4 h.  
Samples were co-stained using C-terminal β-DG antibody and rhodamine-labelled 
secondary antibody.  Corresponding phase images are shown in the bottom panel.  
Arrows point to a DG-/- cell lacking laminin-111-FITC binding.  Bar, 10 μm. 
 
Figure 7.  Re-expression of full length DG or DG mutants in a completely DG-/- cell 
line restored laminin-111 binding on monolayer cell surfaces.  A) Western blot of cell 
extracts (10 μg protein) prepared from DG+/+ cells and a completely DG-/- cell line 
(derived from MEpG cells) infected with retroviral vector (VEC) or that encoding full 
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length DG (wtDG) or various β-DG cytoplasmic deletions (DEL A, B, C).  Blots were 
incubated with antibodies specific for α-DG, N-terminal β-DG (right panel), C-terminal 
β-DG (left panel), or E-cadherin (loading control), followed by HRP-conjugated 
secondary antibodies.  Sizes of molecular weight markers are shown in kDa.  B) Paired 
immunofluorescent images of cells in A, co-stained for α-DG and nuclei, using FITC-
labelled secondary antibody and propidium iodide, respectively.  C) Immunofluorescent 
images of cells in A, treated for 4 h with 10 nM exogenously added laminin-111-FITC.  
Corresponding phase images are shown in the bottom panel.  Bar, 10 μm. 
 
Figure 8.  Expression of full length DG and DG mutants in a completely DG-/- cell 
line restored polarity and surface laminin in a 3-D matrix of collagen I/laminin-111.  
A) Confocal immunofluorescent images taken at the center of colonies grown in collagen 
I (upper panel) or collagen I/laminin-111 (middle panel).  Samples were co-stained for 
ZO-1, α6 integrin, and nuclei as described in Fig. 2A.  Bottom panel shows laminin 
staining of a second group of colonies grown in collagen I/laminin-111, visualized with 
rhodamine-labeled secondary antibody (red).  Cells are described in Fig. 7A.  Bar, 10 μm.  
B) Quantification of polarity in colonies grown in collagen I (C) or collagen I/laminin-
111 (C/L) using ZO-1 as a polarity marker.  Results are shown as the average + SEM of 
3-5 independent experiments, each with triplicate or quadruplicate counts.  (^) or (*) = 
P<0.001 for all paired combinations except with each other. 
 
Figure 9.  Expression of full length DG and DG mutants in a completely DG-/- cell 
line restored β-casein protein expression in response to laminin-111.  Western blot of 
cell extracts prepared from cells infected with retroviral vector (VEC) or that encoding 
full length DG (wtDG) or various β-DG cytoplasmic deletions (DEL A, B, C) and 
incubated with a laminin-111 overlay in the absence (-) or presence (+) of prolactin and 
hydrocortisone.  Blots were incubated with antibodies specific for β-casein or E-cadherin 
(loading control), followed by HRP-conjugated secondary antibodies.  Sizes of molecular 
weight markers are shown in kDa. 
 
Figure 10.  The DG extracellular domain alone is critical to laminin assembly.  A) 
Western blot of cell extracts prepared from a completely DG-/- cell line (derived from 
MEpL cells) infected with retroviral vector (VEC) or that encoding full length DG 
(wtDG), a fusion protein comprised of the extracellular DG sequences fused to the 
transmembrane region of TACE (DG-tmf), or deletions within the α-DG mucin domain 
(DEL D, E).  Blots were incubated with antibodies specific for α-DG, N-terminal β-DG, 
or E-cadherin (loading control).  Sizes of molecular weight markers are shown in kDa.  
B) Immunofluorescent images of cells in A, treated for 4 h with 10 nM exogenously 
added laminin-111-FITC.  Corresponding phase images are shown in the bottom panel.  
Bar, 10 μm.  
 
Figure 11.  Model for DG’s role as a MEC co-receptor in laminin-111 assembly and 
laminin-111-induced functions.  α-DG on the MEC surface serves as the initial 
anchoring site for laminin-111 (LN) monomers by interacting with their C-terminal LG 
domains (step 1).  The laminin-111/DG complexes recruit β1 integrin (INT) co-receptors, 
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which contribute to laminin-111 polymerization (step 2).  Subsequent activation of co-
receptors, possibly integrins (INT), influences intracellular signaling pathways leading to 

































β-DG - 2X LOAD
Figure 1.  Generation of DG+/+ and partial DG-/- MEC populations by adenoviral 
infection of immortalized mouse MECs. A) Diagram of DG, including the extracellular α-
DG subunit, with central mucin domain, and the transmembrane β-DG subunit.  B)  Diagram 
of laminin-111 (LN), including the 3 subunits (α, β, γ), and the 5 C-terminal LG domains, with 
respective receptor binding sites.  C) Western blot of cell extracts (5 ug protein) prepared on 
various days after infection of immortalized floxed DG mouse MEpG cell line with control or 
Cre recombinase-expressing adenovirus to generate DG+/+ and partial DG-/- cell 
populations, respectively.  Lane 1 represents uninfected cells at time 0.  Blots were incubated 
with antibodies specific for α-DG, C-terminal β-DG, or E-cadherin (loading control), followed 
by HRP-conjugated secondary antibodies.  Sizes of molecular weight markers are shown in 
kDa.  D) Vertically paired immunofluorescent images of DG+/+ and partial DG-/- cell 
populations using primary antibodies specific for α-DG or C-terminal β-DG, followed by FITC-
labeled secondary antibodies (upper panel).  Nuclei were stained with propidium iodide 
















































C         C/L
DG+/+
DG-/-
Figure 2.  Loss of polarity in DG-/- colonies grown in a 3-D matrix of collagen I/laminin-
1. DG+/+ and DG-/- cells were grown in a 3-D matrix of collagen I or collagen I/laminin-111  
and co-immunostained.  Confocal immunofluorescent images were taken at colony centers.  
Bar, 10 um.  A) Staining using ZO-1 and α6 integrin antibodies, visualized with FITC- (green) 
and Cy-5- (blue) labeled secondary antibodies, respectively, and propidium iodide to stain 
nuclei (red).  B) Staining using α6 integrin and C-terminal β-DG (insets) antibodies, detected 
with rhodamine- (red) and Cy-5- (blue changed to white for easier visualization) labeled 
secondary antibodies, respectively.  Actin was seen using Alexa Fluor 488 phalloidin (green).  
Overlap between actin and α6 integrin staining appeared yellow.  C) Quantification of polarity 
in DG+/+ and DG-/- colonies grown in collagen I (C) or collagen I/laminin-111 (C/L) using ZO-
1 as a polarity marker.  Results are shown as the average + SEM of 4-6 independent 




























Figure 3.  Loss of laminin binding and DG co-localization on the surface of DG-/-
cells grown in a 3-D matrix of collagen I or collagen I/laminin-111. A) Vertically paired 
confocal immunofluorescent images of DG+/+ and DG-/- cells grown in collagen I or 
collagen I/laminin-111.  Samples were co-immunostained with laminin, α6 integrin, and C-
terminal β-DG (insets) antibodies, followed by rhodamine- (red), FITC- (green), and Cy-5-
(blue changed to white for easier visualization) labelled secondary antibodies, respectively.  
Images were taken at colony centers.  B) Confocal immunofluorescent images taken at the 
cell surface of DG+/+ colonies shown in A to reveal co-staining for laminin, β-DG, and their 































   
Figure 4. DG-/- cell monolayers failed to bind endogenous laminin or exogenous 
laminin-111-FITC.  A) Vertically paired immunofluorescent images of DG+/+ and partial DG-/-
cell populations co-stained using laminin and C-terminal β-DG antibodies, followed by 
rhodamine- and FITC-labelled secondary antibodies, respectively, all in the presence of Tween-
20 (images above line).  Arrows point to a DG-/- cell that retained staining for intracellular, but 
not cell surface, laminin.  Cells immunostained for laminin in the absence of Tween-20 are 
shown below the line, with corresponding phase images.  B) Immunofluorescent images of 
DG+/+ and partial DG-/- cell populations treated with 10 nM exogenously added laminin-111-
FITC for 4 h.  Samples were co-stained using C-terminal β-DG antibody and rhodamine-labelled
secondary antibody.  Corresponding phase images are shown in the bottom panel.  Arrows 
point to a DG-/- cell lacking laminin-111-FITC staining.  C) Immunofluorescent images of DG+/+ 
cells treated with 10 nM exogenous laminin-111-FITC for 24 h in the absence or presence of α6 
and/or β1 integrin function blocking antibodies (upper panel).  Corresponding phase images are 
shown in the bottom panel.  Insets show cells incubated only with 10 nM AEBSF-treated 
laminin-1 for 24 h, followed by immunostaining for laminin as described for upper images in A.  











Figure 5.  Partial DG+/+ colonies grown in a 3-D matrix of collagen I/laminin-111 
retained laminin and DG co-localization on the surface of DG +/+ cells only, but 
failed to polarize.  A) and B) Confocal immunofluorescent images taken at the center of 
partial DG+/+ colonies grown in collagen I/laminin-111 and co-immunostained as follows: 
A) α6 integrin and C-terminal β-DG antibodies were detected using rhodamine- (red) and 
Cy-5- (blue) labelled secondary antibodies, respectively.  Actin was visualized with Alexa
Fluor 488 phalloidin (green).  B) Laminin, α6 integrin, and C-terminal β-DG antibodies were 
detected using rhodamine- (red), FITC- (green), and Cy-5- (blue) labelled secondary 
antibodies, respectively.  Arrows show part of colony surface lacking laminin and β-DG 
staining.  C) Confocal immunofluorescent images were taken at the cell surface of the 
colony shown in B to reveal co-staining for laminin, β-DG, and their extent of co-
localization.  Dotted outline represents outer edge of colony.  Bar, 10 μm.
A)





















Figure 6.  Loss of β-casein production in response to laminin-111 in DG-/- cells.  A) 
Western blot of cell extracts (10 μg protein) prepared from DG+/+ and partial DG-/- cell 
population incubated without or with laminin-111 overlay in the absence (-) or presence (+) 
of prolactin and hydrocortisone.  Blots were incubated with antibodies specific for β-casein 
or E-cadherin (loading control), followed by HRP-conjugated secondary antibodies.  Sizes 
of molecular weight markers are shown in kDa.  Dotted lines separate non-adjacent lanes 
derived from the same blot.  B) Immunofluorescent images of DG+/+ and partial DG-/- cell 
population treated with 10 nM exogenously added laminin-111-FITC for 4 h.  Samples were 
co-stained using C-terminal β-DG antibody and rhodamine-labelled secondary antibody.  
Corresponding phase images are shown in the bottom panel.  Arrows point to a DG-/- cell 

















































Figure 7.  Re-expression of full length DG or DG mutants in a completely DG-/- cell 
line restored laminin-111 binding on monolayer cell surfaces. A) Western blot of cell 
extracts (10 ug protein) prepared from DG+/+ cells and a completely DG-/- cell line 
(derived from MEpG cells) infected with retroviral vector (VEC) or that encoding full length 
DG (wtDG) or various β-DG cytoplasmic deletions (DEL A, B, C).  Blots were incubated 
with antibodies specific for α-DG, N-terminal β-DG (right panel), C-terminal β-DG (left 
panel), or E-cadherin (loading control), followed by HRP-conjugated secondary antibodies.  
Sizes of molecular weight markers are shown in kDa.  B) Paired immunofluorescent
images of cells in A, co-stained for α-DG and nuclei, using FITC-labelled secondary 
antibody and propidium iodide, respectively.  C) Immunofluorescent images of cells in A, 
treated for 4 h with 10 nM exogenously added laminin-111-FITC.  Corresponding phase 
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Figure 8.  Expression of full length DG and DG mutants in a completely DG-/- cell line 
restored polarity and surface laminin in a 3-D matrix of collagen I/laminin-111.  A) 
Confocal immunofluorescent images taken at the center of colonies grown in collagen I 
(upper panel) or collagen I/laminin-111 (middle panel).  Samples were co-stained for ZO-1, 
α6 integrin, and nuclei as described in Fig. 2A.  Bottom panel shows laminin staining of a 
second group of colonies grown in collagen I/laminin-111, visualized with rhodamine-labelled
secondary antibody (red).  Cells are described in Fig. 7A.  Bar, 10 um.  B) Quantification of 
polarity in colonies grown in collagen I (C) or collagen I/laminin-111 (C/L) using ZO-1 as a 
polarity marker.  Results are shown as the average + SEM of 3-5 independent experiments, 
each with triplicate or quadruplicate counts.  (^) or (*) = P<0.001 for all paired combinations 
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Figure 9.  Expression of full length DG and DG mutants in a completely DG-/- cell line 
restored β-casein protein expression in response to laminin-111. Western blot of cell 
extracts (10 ug protein) prepared from cells infected with retroviral vector (VEC) or that 
encoding full length DG (wtDG) or various β-DG cytoplasmic deletions (DEL A, B, C) and 
incubated with a laminin-111 overlay in the absence (-) or presence (+) of prolactin and 
hydrocortisone.  Blots were incubated with antibodies specific for β-casein or E-cadherin
(loading control), followed by HRP-conjugated secondary antibodies.  Sizes of molecular 
weight markers are shown in kDa. 



























Figure 10. The DG extracellular domain alone is critical to laminin assembly. A) 
Western blot of cell extracts prepared from a completely DG-/- cell line (derived from 
MEpL cells) infected with retroviral vector (VEC) or that encoding full length DG 
(wtDG), a fusion protein comprised of the extracellular DG sequences fused to the 
transmembrane region of TACE (DG-tmf), or deletions within the α-DG mucin domain 
(DEL D, E).  Blots were incubated with antibodies specific for α-DG, N-terminal β-DG, 
or E-cadherin (loading control).  Sizes of molecular weight markers are shown in kDa.  
B) Immunofluorescent images of cells in A, treated for 4 h with 10 nM exogenously 
added laminin-111-FITC.  Corresponding phase images are shown in the bottom 
panel.  Bar, 10 μm. 
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Figure 11.  Model for DG’s role as a MEC co-receptor in laminin-111 assembly and 
laminin-111-induced functions. α-DG on the MEC surface serves as the initial 
binding site for laminin-111 (LN) monomers by interacting with their C-terminal LG 
domains (step 1).  The laminin-1/DG complexes recruit β1 integrin (INT) co-receptors, 
which contribute to laminin-111 polymerization (step 2).   Subsequent activation of co-
receptors, possibly integrins (INT), influences intracellular signaling pathways leading to 

















Fig. S1. Established cell lines display epithelial markers before and after adenoviral 
infection.  Monolayers of uninfected MEpG cells (left panel) or those infected with 
either a control or Cre-expressing adenovirus to generate DG+/+ cells (middle panel) 
or DG-/- cells (right panel), respectively, were fixed in acetone/methanol and 
immunostained as described in Materials and methods.  Mouse mAb specific for E-
cadherin (BD Transduction Labs) was used at 1:200.  Rat mAb TROMA-1 specific for 
keratin 8 was used at 1:30 (obtained from Developmental Studies Hybridoma Bank 
under the auspices of the NICHD; maintained by University of Iowa, Dept. of Biol. 
Sciences, Iowa City, IA) (Kemler et al., 1981).  Both of the former antibodies were 
visualized with FITC-conjugated secondary antibodies (green).  Rabbit pAb specific for 
ZO-1 (Zymed) was used at 1:100 and detected with rhodamine-conjugated secondary 
antibody (red).  Images were captured using a Nikon Eclipse E800 microscope, SPOT 
camera (Diagnostic Instruments Inc), Image-Pro Plus 3.0.01.00 software (Media 
Cybernetics), and a Nikon Plan Fluor Ph1 DLL 20X objective (0.50 NA).  Bar, 60 um.
A) DG+/+
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Fig. S2.  DG protein levels in DG+/+ and partial DG-/- MEC populations generated by 
adenoviral infection of the MEpL cell line.  Shown in A is a Western blot of cell extracts 
(10 ug protein) prepared on various days after infection of immortalized floxed DG mouse 
MEpL cell line with control or Cre recombinase-expressing adenovirus to generate DG+/+ 
or partial DG-/- cell populations, respectively.  Lane 1 represents uninfected cells at time 
0.  Antibodies are described in the legend for Fig. 1.  Sizes of molecular weight markers 
are given in kDa.  Shown in B are vertically paired immunofluorescent images of DG+/+ 
and partial DG-/- cell populations that were stained using a C-terminal β-DG antibody 
followed by a FITC-labeled secondary antibody (upper panel).  Nuclei were stained with 
propidium iodide (bottom panel).  Bar, 60 um. 
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Fig. S3. Diagram of DG mutants.  Shown are the structures of full length DG (wtDG), 
deletion mutants (DEL A, B, C, D, and E) and the transmembrane fusion mutant (DG-tmf), 
consisting of extracellular DG sequences fused to the transmembrane domain of TACE.  
Numbers refer to amino acids in human α- and β-DG, with deleted sequences shown by 
dotted lines.  “PM” refers to the plasma membrane.”TM” refers to the transmembrane
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